All News about Novartis Ag ADR
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_annie-spratt-hwjsonawtqs-unsplash.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2795.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2786.png)
Super Generic Drugs Market to See Major Growth by 2027 : Lupin, Apotex, Sanofi, Aurobindo, Dr.Reddy's
December 09, 2021
Via SBWire
Topics
Supply Chain
Exposures
Supply Chain
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_3838.jpeg?width=720)
![](https://www.investors.com/wp-content/uploads/2021/12/Stock-Aurinia-01-shutt.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/laboratory-g91232d1d0_1920.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2707.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_3754.jpeg?width=720)
![](https://investorplace.com/wp-content/uploads/2019/09/deal-handshake.jpg)
AI for Pharma and Biotech Market Next Big Thing : Major Giants Atomwise, CloudMedX, Roche
December 02, 2021
Via SBWire
Topics
Artificial Intelligence
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/photo-1578496781985-452d4a934d50_1.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_389.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Mr. Market Will Shop ‘til He Drops!
December 01, 2021
Via Talk Markets
How one mother is raising awareness for spinal muscular atrophy – a leading genetic cause of infant death
December 01, 2021
Via Brandpoint
Exposures
Product Safety
![](https://investorplace.com/wp-content/uploads/2019/07/drug_stocks1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2650.png)
Molecular Partners Says Its COVID-19 Antiviral Still Effective Against Positions Mutated In Omicron
November 30, 2021
Via Benzinga
Exposures
COVID-19
![](https://g.foolcdn.com/editorial/images/654499/female-scientists.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2594.png)
![](https://www.investors.com/wp-content/uploads/2019/12/stock-Alnylam-01-shutter.jpg)
![](https://g.foolcdn.com/editorial/images/654160/cancer-cells.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.